Skip to main content
editorial
. 2006 Oct 7;12(37):6041–6045. doi: 10.3748/wjg.v12.i37.6041

Table 1.

Correlation of DAB2 protein expression with clinicopathological parameters of ESCC patients

Parameters Total cases DAB2
n Positive n (%) Negative n (%)
ESCC 50 16 (32) 34 (68)
Age
≤ 40 yr 14 4 (28) 10 (72)
≥ 40 yr 36 12 (33) 24 (67)
Gender
Male 30 11 (37) 19 (63)
Female 20 5 (25) 15 (75)
Tumor Stage
T2 3 1 2
T3 36 11 (31) 25 (69)
T4 11 4 (36) 7 (64)
Hp Grading
WDSCC 8 2 6
MDSCC 37 11 (30) 26 (70)
PDSCC 5 3 (60) 2 (40)
Nodal stage
Node -ve 23 8 (35) 15 (65)
Node +ve 27 8 (30) 19 (70)
Normal 10 10
Hyperplasia 30 25 (83) 5
Dysplasia 15 5 10 (67)